Searched for
KILITCH HEALTHCARE
Budget 2026 wish-list: Pharma sector seeks API self-reliance, export incentives to strengthen India’s ‘Pharmacy of the World’ tagAhead of the Union Budget 2026, pharma players push for API self-reliance and export competitiveness.- Mukul Agrawal purchases 10 new stocks in Q2; ups stake in 5. How many do you own?Ace investor Mukul Agrawal significantly reshaped his Rs 7,500 crore portfolio in Q2, adding ten new stocks and increasing stakes in five o...
- Pharma's exemption from reciprocal tariffs underscores generic medicines' critical role globallyThe US Administration has exempted pharmaceuticals from reciprocal tariffs, highlighting the significance of affordable, life-saving generi...
- USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plantThe US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses at its plant i...
- Desi pharma pangs continue for India despite dose to fortify pharmacy of the world tagIndia, once the 'pharmacy of the world', is struggling to establish itself as an elite player due to poor manufacturing practices that have...
- Indian eyedrop maker issues recall of various eye drops in US for potential safety reasonsKilitch Healthcare India Limited has recalled 27 types of eye drops sold in the U.S. due to safety concerns arising from insanitary conditi...
- Ahead of Market: 12 things that will decide stock action on FridayChandan Taparia of MOFSL said, Nifty has to hold above 11,700 level to witness a further bounce towards 11,900 and 12,000 levels, while on ...
- After Market: Rs 1.10 lakh crore gone in two days, 109 stocks signal fallMidcaps and smallcaps indices closed 0.28 per cent and 0.16 per cent down, respectively.
- After Market: SBI’s sweet surprise, new Adani stock & day’s big showsShares of Som Distilleries, ATN Intnl, Venky’s, Kirloskar Brothers and Gammon Infra were among the top losers on NSE.
- 64 stocks doubled money in Samvat 2074: What’s in store for New YearThe BSE Sensex is up 6% since last Diwali, whereas the BSE Midcap index is down 9%.
- Is your portfolio anaemic? Careful, the pharma pill may not help defend against vulnerabilityBrokerages turned cautious on the sector just ahead of September quarter earnings.
- Pharma stocks for defensive bias or to gain from weak rupee? Must read thisNifty Pharma index outpaced the benchmark index which slipped more than 1 per cent.
- Titan, Aster DM among 15 stocks ready to rally, shows MACDAnalysts said any bounce at this stage may be shallow and traders must exercise caution.
- Mapping the market: Midcaps, smallcaps stay positive; seven stocks that gained up to 20%As the mkt was drawing up confidence to notch up healthy gains, Saudi Arabia played spoilsport, by dashing hopes of an output-limiting deal...
Load More
